index
At Novartis, we are reimagining medicine
Novartis Financial Results – Q2 2021
Novartis announced the company’s financial results for the second quarter and first half of 2021.
Learning, Connecting and Moving Forward Together
The Day of Reflection, Forward Together, is an annual event that is an opportunity for everyone to engage in listening & learning - to connect, reflect & discover the many ways we can be more inclusive & engage.
Addressing health inequities starts by looking within
The Novartis US Foundation has partnered with the Institute for Healthcare Improvement to help healthcare systems better serve patients.
COVID-19 US Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Novartis in Society 2020 US Report
Novartis is striving every day to help patients, strengthen communities, drive sustainability, and build a more equitable and responsive healthcare system for all.
Notice to Healthcare Providers and Entities
Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services.
Novartis US at a Glance
Learn more about Novartis in the US and our impact on patients, families and their communities.
NIBR Science of Therapeutics Symposium: Coronavirus Antivirals
Watch videos from our ‘hard core’ science event focused on finding therapeutic solutions to this ongoing health crisis.
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Standing for Racial Equity and Justice as One Novartis
We believe unequivocally that Black Lives Matter. As a company focused on improving human health globally, we also recognize the disparities Black communities and communities of color face when it comes to healthcare.